A retrospective study of factors associated with an increased risk of developing renal failure in multiple myeloma patients while on carfilzomib therapy
Latest Information Update: 11 May 2021
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 May 2021 New trial record
- 01 May 2021 Results published in the Annals of Hematology